AgencyIQ – FDA proposes guidance for dose optimization in oncology trials
Background on dose-finding in oncology In the early phases of clinical development of oncology products, sponsors conduct dose-finding studies to determine the maximum tolerated dose (MTD) of an investigational product. MTD seeks to find the tolerability and safety of treatment at the highest dose that can both be tolerated and treat the cancer. There are several…